Tango Therapeutics (TNGX) reported that it is "aware of the current situation affecting Silicon Valley Bank (SIVB), it is monitoring this situation closely and does not expect its exposure to SVB will require any change to its previously provided guidance that it has sufficient cash, cash equivalents and marketable securities to fund operations into 2025."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TNGX:
- Tango Therapeutics Announces Limited Exposure to Silicon Valley Bank
- Tango Therapeutics announces inducement grants under Nasdaq listing rule
- Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Tango Therapeutics appoints Crystal as President of Research, Development
- Tango Therapeutics to Participate in Upcoming Investor Conferences
